Literature DB >> 7908343

Neuroprotective activity of acetyl-L-carnitine: studies in vitro.

G Forloni1, N Angeretti, S Smiroldo.   

Abstract

The neuroprotective properties of acetyl-L-carnitine (ALCAR) were investigated in primary cell cultures from rat hippocampal formation and cerebral cortex of 17-day-old rat embryos. Chronic exposure to ALCAR (10-50 microM for 10 days) reduced the cell mortality induced by 24 hr fetal calf serum deprivation. Protection was partial when the neuronal cells, chronically treated with ALCAR (50 microM), were exposed to glutamate (0.25-1 mM) and kainic acid (250-500 microM) for 24 hr. The neurotoxicity induced by N-methyl-D-aspartate (NMDA, 250 microM) was attenuated by the acute co-exposure with ALCAR (1 mM), the chronic treatment with ALCAR (50 microM) significantly reduced the neuronal death induced by NMDA (0.25-1 mM). Cell mortality was also investigated in ALCAR-treated hippocampal cultures chronically treated with beta-amyloid fragment 25-35. ALCAR appeared to have neuroprotective activity. This suggests an explanation of the positive results obtained with ALCAR in the treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908343     DOI: 10.1002/jnr.490370112

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

Review 1.  A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors:  Nahla E El-Ashmawy; Rania M Khalil
Journal:  Tumour Biol       Date:  2013-12-12

Review 2.  Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

Authors:  Gregory E Bigford; Gianluca Del Rossi
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

Review 3.  Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

Authors:  Santina A Zanelli; Nina J Solenski; Robert E Rosenthal; Gary Fiskum
Journal:  Ann N Y Acad Sci       Date:  2005-08       Impact factor: 5.691

4.  Acetyl-L-carnitine arginine amide prevents beta 25-35-induced neurotoxicity in cerebellar granule cells.

Authors:  A Scorziello; O Meucci; M Calvani; G Schettini
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

Review 5.  Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.

Authors:  G J Moyle; M Sadler
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

6.  Intrathecal Acetyl-L-Carnitine Protects Tissue and Improves Function after a Mild Contusive Spinal Cord Injury in Rats.

Authors:  Eric E Ewan; Theo Hagg
Journal:  J Neurotrauma       Date:  2015-12-02       Impact factor: 5.269

7.  Tolerability and efficacy of L-acetylcarnitine in patients with peripheral neuropathies: a short-term, open multicentre study.

Authors:  D D Grandis
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  CSPGs inhibit axon branching by impairing mitochondria-dependent regulation of actin dynamics and axonal translation.

Authors:  Rajiv Sainath; Andrea Ketschek; Leah Grandi; Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2016-08-02       Impact factor: 3.964

9.  L-Acetylcarnitine in the Treatment of Patients with Peripheral Neuropathies : A Short Term, Double-Blind Clinical Study of 426 Patients.

Authors:  D De Grandis; L Santoro; P Di Benedetto
Journal:  Clin Drug Investig       Date:  1995-12       Impact factor: 2.859

Review 10.  Acetyl-L-carnitine for dementia.

Authors:  S Hudson; N Tabet
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.